Member Info for Livedataaccount

Hi trek. I think your best bet is the fca daily short spreadsheet
https://www.fca.org.uk/publication/data/short-positions-daily-update.xlsx&ved=2ahUKEwi--NDv7q7yAhVpr5UCHRP0CC8QFnoECAwQAQ&sqi=2&usg=AOvVaw06xgJNLygRkuTA8rE1ntGk

Be good to find out whether there are any big corporates / governments currently trialling the affidx test.

Mike, that's a fair question. Not one I'm able to answer. Just find the lft situation odd.

No, they don't at all. It's all rather baffling. Last presentation if I recall correctly AS said they were a couple of weeks ago from TT with Abdx. That was obviously much more than a couple of weeks ago now.

I say baffling. Avacta released an RNS last September saying they were in TT transfer with Abdx.

Maybe the whole industry is in a mess, so unfair to lay the blame at AS?

Hyper. No much too big for a postbox. 25 tests per box.

I find it hard to believe this whole mess started from a bat at a wet market in China. If it had surely China would close every wet market and stop eating obscure animals immediately to stop it happening again.

No, but if after a short period my dosage of paracetamol is gradually increased and I show signs of recovery without side effects I am therefore beating treated.

MrA. By dosing the patient they are effectively treating the patient. All beit starting slowly and upping the dosage whilst monitoring the side effects and effect it has on the tumour.

Otherwise what's the point in the participant taking part in the study if he has no chance of improving.

Are we to assume AS is back from is holidays now? And Paul can do another excitable interview? Hope so!

Would a potential suitor who wants to buyout Avacta be given access to the results before they are announced to the market?

So there we are. A great RNS publicising the fact Avacta are now a clinical biotech. Great news the Lateral Flow Test too as there will be a lot of more eyeballs on Avacta now.

It's a fair question. Would a small biotech usually announce dosing of first patient? I would have thought so as its great publicity.

But I do get the impression as has been discussed here. Avacta have been bombarded with queries from private investors. So maybe they won't. Anyway should find out shortly.

Oh for crying out loud, Wyndrum! AS will update the market ONLY when he has significant news to release. He has said this twice now authoratively in recent presentations.

Therein lies the problem. Waiting for a monster Rns! That's dreaming. It should be a steady stream of news after the projections made by the company.

It's all very well cracking jokes. But what exactly is the situation for avacta?

At the presentation. Circa 6 weeks ago AS said the were weeks away for tech transfer to Abingdon. No update. There was also an RNS circa 10 months ago saying Avacta were in tech transfer with Abingdon etc etc.
In discussion with 27 or so parties from near on every continent.
As it stands. In public knowledge bioserv are receiving a deliver every couple of weeks of Avacta Lfts.

It isn't his company though. It's a Plc.

My gripe is some of the targets AS has mentioned for the last 18 months.

They may well come off and I hope they do but I believe he would have been better to reign it in a bit.

It's not as simple as just selling to an airline is it? Surely depends on the countries regulations on testing. Eg. UK government is test and trace day 2 and 8 etc. Using approved suppliers.

Was it an Avacta lft?

Why are Avacta making bioserv wait 2 weeks until they ship out tests for the next order?

Just seems odd when bioserv are Avacta's only reseller

They should already have most of the detail signing off the CE mark.